Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från IRLAB Therapeutics via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-09-13 08:45:00
Gothenburg, Sweden, September 13, 2022 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease, today announced that Richard Godfrey, CEO of IRLAB, will present at ABGSC Investor Day on Tuesday, September 13, 2022, at 16:30 am CEST.
The event is a hybrid format with in-person presentations in Stockholm, Sweden, and virtual presentations. Richard Godfrey will be presenting remotely. A recording of the presentation will be made available on the company website, www.irlab.se, following the event.